In this issue:
Cost-effectiveness and qualityadjusted survival of watch and wait in rectal cancer
COVID-19 and impact of diagnosis delays on cancer deaths in the UK
Adjuvant imatinib for high-risk GIST patients
Cisplatin + fluorouracil vs carboplatin + paclitaxel in advanced anal cancer
Lenvatinib plus pembrolizumab advanced gastric cancer
FOLFIRINOX for advanced gastroesophageal cancers
Margetuximab plus pembrolizumab in previously treated, HER2+ gastro-oesophageal adenocarcinoma
Regorafenib for locally advanced/ metastatic biliary tumours
Effect of perioperative COX2 and β-adrenergic blockade on colorectal cancer biomarkers
Mindfulness-based interventions and anxiety severity in cancer patients
Please login below to download this issue (PDF)